Patrick G Johnston Centre for Cancer Research: against COVID-19 Hub
Ken Mills' research has focused on improving diagnosis, prognosis and prediction of therapeutic responses for blood cancers at this Hub. Now he is part of a cross-disciplinary research team that is testing whether current drugs can be “repurposed” to treat COVID-19. 2. https://pubmed.ncbi.nlm.nih.gov/32335477/
Connections from
.jpg)
.jpg)
Funding Status:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Technology:
COVID Labs/Universities
Employee Number:
N/A
Number Of Exists:
N/A
Industry:
COVID R&D